2Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychophamacol, 1990,10 : 244-251.
3Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. J Clin Monit,1994,10 : 392-404.
4Glass PS,Bloom M,Kearse L. et al. Bispectral analysis measures sedation and memory effects of propofol,midazolam,isoflurane, and alfentanil in healthy volunteers Anesthesiology, 1997,86 : 836-847.
5Dundee JW, Halliday NJ, Harper KW,et al. Midazolam.A review of its pharmacological properties and therapeutic use Durgs, 1984,28 : 519-543.
6Kanto J,Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmaeokinet, 1989,17:308-326.
7Albrecht S, Ihmsen H, Hering W, et al. The effects of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther, 1999,65 : 630-639.
8Leslie K, Sessler DI, Sehroeder M, et al. Propofol blood concentration and the bispectral index prediet suppression of learning during propofol/epidural anesthesia in volunteers. Anesth Analg, 1995,81 : 1269-1274.
9Chernik DA,Gillings D, Laine H, et al. Validity and reliability of the observer's assessment of alertness/sedation scale:study with intravenous midazolam, J Clin Psychopharmacol, 1990,10 : 244-245.
10Edewards M, Serrao JM, Gent JP, et al. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology, 1990,73 : 273-277.
